Ignite Creation Date:
2024-05-06 @ 8:05 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06248515
Status:
RECRUITING
Last Update Posted:
2024-05-29
First Post:
2024-01-31
Brief Title:
A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors
Sponsor:
Georgetown University
Organization:
Georgetown University
Organization Data
Organization:
Georgetown University
Class:
OTHER
Study ID:
STUDY00007501
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Georgetown University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Gilead Sciences | INDUSTRY |